EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,198 | -56.7% | 33,436 | 0.0% | 0.00% | – |
| Q2 2023 | $23,539 | -72.6% | 33,436 | -65.1% | 0.00% | – |
| Q1 2023 | $85,958 | -35.1% | 95,839 | -14.7% | 0.00% | – |
| Q4 2022 | $132,533 | -83.8% | 112,316 | +3.5% | 0.00% | – |
| Q3 2022 | $818,000 | +21.9% | 108,528 | +1.9% | 0.00% | – |
| Q2 2022 | $671,000 | -9.0% | 106,502 | +20.1% | 0.00% | – |
| Q1 2022 | $737,000 | +63.4% | 88,711 | +2.3% | 0.00% | – |
| Q4 2021 | $451,000 | -22.2% | 86,758 | 0.0% | 0.00% | – |
| Q3 2021 | $580,000 | -18.1% | 86,758 | +4.5% | 0.00% | – |
| Q2 2021 | $708,000 | +4.0% | 83,031 | +7.9% | 0.00% | – |
| Q1 2021 | $681,000 | -25.3% | 76,931 | +3.7% | 0.00% | – |
| Q4 2020 | $912,000 | +66.1% | 74,188 | +10.1% | 0.00% | – |
| Q3 2020 | $549,000 | -7.4% | 67,387 | +9.2% | 0.00% | – |
| Q2 2020 | $593,000 | +45.3% | 61,701 | +3.0% | 0.00% | – |
| Q1 2020 | $408,000 | -55.0% | 59,879 | -1.5% | 0.00% | – |
| Q4 2019 | $906,000 | +65.6% | 60,803 | +13.9% | 0.00% | – |
| Q3 2019 | $547,000 | -3.4% | 53,360 | 0.0% | 0.00% | – |
| Q2 2019 | $566,000 | – | 53,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $14,118,000 | 3.56% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $12,637,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $3,044,000 | 0.52% |
| Boxer Capital, LLC | 138,331 | $1,093,000 | 0.26% |
| DAFNA Capital Management LLC | 35,977 | $284,000 | 0.20% |
| SABBY MANAGEMENT, LLC | 223,100 | $1,762,000 | 0.12% |
| Hikari Power Ltd | 60,992 | $482,000 | 0.06% |
| Perceptive Advisors | 157,679 | $1,245,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 90,000 | $711,000 | 0.06% |
| TFS CAPITAL LLC | 12,128 | $96,000 | 0.04% |